Stock Alert: Lemonade Gains 8%

By RTTNews Staff Write  ✉   | Published:

Shares of Lemonade Inc. (LMND), a New York-based online insurance company, are rising almost 8 percent or $8.33 in Tuesday's morning trade at $116.00.

According to Lemonade's IPO prospectus, about 44 million of the company's shares will be eligible for sale on Tuesday as the lock-up period on insider sales expires. The shares are mostly held by insiders.

Lemonade has traded in a range of $44.11 to $137.30 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration approved the first generic drug to treat severe hypoglycaemia or dangerously low blood sugar levels, which could occur in patients with diabetes mellitus and who are using insulin treatment. Amphastar Pharmaceuticals' glucagon for injection USP, 1 mg/vial, packaged in an emergency kit, is the first-ever FDA approval of a generic version of rDNA Glucagon. King of Fans has recalled Hampton Bay Mara ceiling fans that were sold exclusively at Home Depot citing issues with blades, according to the U.S. Consumer Product Safety Commission. The recall was initiated after reports of fans' blades flying off, injuring people and causing damage to property. The U.S. Securities and Exchange Commission said Monday that President Donald Trump has designated Elad Roisman as acting Chairman of the agency.